Sunday 27 March 2011

Flucozal




Flucozal may be available in the countries listed below.


Ingredient matches for Flucozal



Fluconazole

Fluconazole is reported as an ingredient of Flucozal in the following countries:


  • Bulgaria

  • Malta

International Drug Name Search

Monday 21 March 2011

Aminophenazone




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N02BB03

CAS registry number (Chemical Abstracts Service)

0000058-15-1

Chemical Formula

C13-H17-N3-O

Molecular Weight

231

Therapeutic Categories

Analgesic, antipyretic and anti-inflammatory agent

Non-steroidal anti-inflammatory drug, NSAID

Chemical Name

3H-Pyrazol-3-one, 4-(dimethylamino)-1,2-dihydro-1,5-dimethyl-2-phenyl-

Foreign Names

  • Aminophenazonum (Latin)
  • Aminophenazon (German)
  • Aminophénazone (French)
  • Aminofenazona (Spanish)

Generic Names

  • Aminofenazone (OS: DCIT)
  • Aminophénazone (OS: DCF)
  • Amidofebrin (IS)
  • Amidophenazon (IS)
  • Amidopyrin (IS)
  • Aminopyrine (IS)
  • Diamin (IS)
  • Dimethylaminaphenazon (IS)
  • Dimethylaminoantipyrin (IS)
  • Dipyrin (IS)
  • Pyramidon (IS)
  • Aminofenazone (PH: F.U. IX)
  • Aminophenazonum (PH: Ph. Helv. VI, Editio, Ph. Int. 2)
  • Amminofenazone (PH: F.U. VIII)

Brand Name

  • Amidophen
    Sopharma, Bulgaria

International Drug Name Search

Glossary

DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday 7 March 2011

Cefradril




Cefradril may be available in the countries listed below.


Ingredient matches for Cefradril



Cefadroxil

Cefadroxil monohydrate (a derivative of Cefadroxil) is reported as an ingredient of Cefradril in the following countries:


  • Oman

International Drug Name Search

Saturday 5 March 2011

DDAVP


Pronunciation: DES-moe-PRES-in
Generic Name: Desmopressin
Brand Name: DDAVP


DDAVP is used for:

Treating nighttime bedwetting. It is also used to manage temporarily increased thirst and urination caused by head injury or certain types of brain surgery, or to manage certain types of diabetes (cranial diabetes insipidus). It may also be used for other conditions as determined by your doctor.


DDAVP is an antidiuretic hormone. It works by causing the kidneys to produce less urine.


Do NOT use DDAVP if:


  • you are allergic to any ingredient in DDAVP

  • you have moderate to severe kidney problems

  • you have or have a history of low blood sodium levels (salt depletion)

Contact your doctor or health care provider right away if any of these apply to you.



Before using DDAVP:


Some medical conditions may interact with DDAVP. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have severe drowsiness

  • if you have a history of kidney problems, heart problems (eg, heart blood vessel problems), or high blood pressure

  • if you have cystic fibrosis, dehydration, fever, severe infection, vomiting or diarrhea, swelling or fluid retention, or abnormal blood electrolyte levels

  • if you are exposed to very hot weather, are physically active, or drink a lot of water

  • if you have recently had surgery in the head area

Some MEDICINES MAY INTERACT with DDAVP. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Carbamazepine, chlorpromazine, lamotrigine, narcotic analgesics (eg, codeine), nonsteroidal anti-inflammatory drugs (NSAIDs) (eg, ibuprofen), oxybutynin, selective serotonin reuptake inhibitors (SSRIs) (eg, fluoxetine), or tricyclic antidepressants (eg, imipramine) because the risk of fluid overload with low blood sodium levels may be increased

Ask your health care provider if DDAVP may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use DDAVP:


Use DDAVP as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take DDAVP by mouth with or without food.

  • If you miss a dose of DDAVP, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use DDAVP.



Important safety information:


  • DDAVP may cause dizziness. These effects may be worse if you take it with alcohol or certain medicines. Use DDAVP with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Follow the fluid intake instructions given to you by your health care provider very carefully. Serious side effects may occur if you drink too much liquid while taking DDAVP.

  • Check with your doctor if you experience infection, fever, vomiting, or diarrhea. Tell your doctor if you will be exposed to very hot weather, will be physically active, or will be increasing your water intake for any reason. The risk of low blood sodium levels may be increased.

  • Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor.

  • Tell your doctor or dentist that you take DDAVP before you receive any medical or dental care, emergency care, or surgery.

  • Lab tests, including urine volume or blood electrolyte levels, may be performed while you use DDAVP. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

  • Use DDAVP with caution in the ELDERLY and in CHILDREN; they may be more sensitive to its effects, especially water overload. Signs of water overload may include severe or persistent nausea or headache, vomiting, or unusual weight gain.

  • DDAVP should be used with extreme caution in CHILDREN younger than 6 years old if used for nighttime bedwetting; effectiveness for bedwetting in these children has not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using DDAVP while you are pregnant. It is not known if DDAVP is found in breast milk. If you are or will be breast-feeding while you are using DDAVP, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of DDAVP:


All medicines may cause side effects, but many people have no, or minor, side effects. No COMMON side effects have been reported with DDAVP. Seek medical attention right away if any of these SEVERE side effects occur:



Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); confusion; fainting; loss of appetite; mental or mood changes (eg, agitation, irritability); muscle weakness, spasms, or cramps; nausea; personality changes; seizures; swelling; unusual headache or restlessness; unusual tiredness or sluggishness; unusual weight gain; vomiting.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: DDAVP side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include confusion; persistent headache; sudden weight gain; trouble urinating; unusual drowsiness.


Proper storage of DDAVP:

Store DDAVP at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, moisture, and light. Keep DDAVP out of the reach of children and away from pets.


General information:


  • If you have any questions about DDAVP, please talk with your doctor, pharmacist, or other health care provider.

  • DDAVP is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about DDAVP. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More DDAVP resources


  • DDAVP Side Effects (in more detail)
  • DDAVP Dosage
  • DDAVP Use in Pregnancy & Breastfeeding
  • Drug Images
  • DDAVP Drug Interactions
  • DDAVP Support Group
  • 6 Reviews for DDAVP - Add your own review/rating


  • DDAVP Concise Consumer Information (Cerner Multum)

  • DDAVP Prescribing Information (FDA)

  • DDAVP Advanced Consumer (Micromedex) - Includes Dosage Information

  • Desmopressin Prescribing Information (FDA)

  • DDAVP Rhinal Tube nasal Concise Consumer Information (Cerner Multum)

  • Desmopressin Acetate Monograph (AHFS DI)

  • Stimate Prescribing Information (FDA)



Compare DDAVP with other medications


  • Diabetes Insipidus
  • Hemophilia A
  • Primary Nocturnal Enuresis
  • von Willebrand's Disease

Tuesday 1 March 2011

Esam




Esam may be available in the countries listed below.


Ingredient matches for Esam



Amlodipine

Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Esam in the following countries:


  • Myanmar

International Drug Name Search